The scientific community said goodbye to Sydney Brenner, Paul Greengard, Patricia Bath, and a number of other leading researchers this year.

The new policy will increase scrutiny and pressure on stem cell clinics, according to industry experts.

A trial is recruiting patients to test the gene-editing technology’s ability to treat an inherited form of blindness caused by a mutation in the CEP290 gene.

The UCLA ophthalmologist worked to combat blindness in underserved communities.

Age-related macular degeneration patients who received injections of retinal cells derived from donors’ induced pluripotent stem cells have maintained their level of eyesight for a year.

Blind rats are made to see after sheets of cells implanted into their eyes make themselves at home.

Researchers stumbled across the connection while searching for ways to reduce vision problems in people with achromatopsia.

Two studies identify a signaling pathway that contributes to the fish’s sleeplessness.

Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.